Low-Fidelity Driving Simulator Training in Parkinson's Disease. (NCT07463755)
Low-Fidelity Driving Simulator Training and Driving Outcomes in Parkinson's Disease: A Pilot Randomized Control Study
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if low-fidelity driving simulator training works to improve cognitive performance, driving behavior, and driving aptitude in individuals with Parkinson's disease. The main questions it aims to answer are: * Does low-fidelity driving simulator training improve cognitive performance? * Does low-fidelity driving simulator training improve driving performance? * Does low-fidelity driving simulator training improve driving aptitude? Researchers will compare driving simulator training to no-training (waitlist control group) to see if the low-fidelity driving simulator is effective in individuals with Parkinson's disease. Participants will: * Undergo 10 sessions of driving simulator training or be placed in the no-training group. * Training group participants will visit the driving simulator lab 2-3 times a week for 4 weeks for training. * Paper-based tests and driving simulator tests will be done before and after 10 sessions of training (or a waiting period).
Who can join: Review the eligibility criteria below.
Location: Mobility and Falls Lab — Kansas City, Kansas
Age range: 30 Years
🧪 Interventions in This Study
- Low-fidelity driving simulator training (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Mobility and Falls Lab — Kansas City, Kansas
📞 Contact the Study Coordinator
Phone: (913) 588-5235
Email: aakinwuntan@kumc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson's Disease (PD)
- Relative Bioavailability Study of HNC364 Injectable Suspension — Secaucus, New Jersey
- Accelerated TMS for Freezing of Gait in Parkinson's Disease — Charleston, South Carolina
- Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) — Sacramento, California
Explore by condition: All Parkinson's Disease (PD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.